AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
ICMR reopens the call for EoI for development of mAbs against Nipah virus due to inadequate responses: Shardul Nautiyal, Mumbai Wednesday, December 17, 2025, 08:00 Hrs [IST] Due t ...
IPC 2025 to accelerate HR strengthening in life sciences as technology & talent converge: Nandita Vijayasimha, Bengaluru Wednesday, December 17, 2025, 08:00 Hrs [IST] As the life ...
AKCDA seeks DCGI’s intervention in fake drug scandal at Kerala's discount pharmacies: Peethaambaran Kunnathoor, Chennai Wednesday, December 17, 2025, 08:00 Hrs [IST] The All Ker ...
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has recently expressed concern over the partnership between Swiggy Instamart and PharmEasy for a rapid drug delivery model in ...
Smart manufacturing & advanced pharmaceuticals to shape the future by 2030: Kaushik Desai: Nandita Vijayasimha Bengaluru Wednesday, December 17, 2025, 08:00 Hrs [IST] By 2030, the ...
AP pharmacists raise alarm over council election irregularities, petition filed in HC: Peethaambaran Kunnathoor, Chennai Wednesday, December 17, 2025, 08:00 Hrs [IST] Registered p ...
Reshaping talent acquisition in pharma through recruitment process outsourcing Pharmaceutical companies face growing pressure to meet commercial launch timelines, often while hiring across unfamiliar ...
CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...
The 3rd Edition of Remarkable Women Camaraderie 2026 & Awards, set to take place on February 6, 2026, in Goa, is born from the belief that when women come together, exchange stories, and uplift one ...
Dimerix completes patient enrolment in ACTION3 phase 3 trial of DMX-200 to treat focal segmental glomerulosclerosis: Melbourne, Australia Tuesday, December 16, 2025, 18:00 Hrs [IS ...